Walgreens Boots Alliance post impressive Q2 earnings that beat analysts’ estimates due to Omicron-led demand for vaccines, according to a news release by Walgreens on Thursday.

  • Sales jumped to $33.76 billion in Q2 from $32.78 billion a year earlier and topped the $33.4 billion that analysts anticipated.
  • In the quarter, net income dropped to $883 million or $10.2 per share, from $1.03 billion, or $1.19 per share, a year earlier.
  • Walgreens stated that same-store sales for retail in the US rose 14.7% in the quarter compared with the same quarter in 2021, the largest gain in over 20 years.
  • The company also reported gains in all categories, more so health and wellness items.
  • For its UK-based stores, retail same-store sales soared 22% year-over-year, with market share gains across all key categories.

The drugstore chain stated it administered 11.8 million Covid vaccines in Q2, bringing its total to more than 62.8 vaccines to date. WBA: NASDAQ is down 1.62%, pre-market trading